A Study Of RC-031 Consumption On Exercise Performance

Overview

About this study

The purpose of this study is to determine the impact of RC-031 oral consumption on human exercise performance and recovery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Aged between 18-50 yrs
Active at moderate to high intensities regularly (3-5 days/week)
Not using nutritional or dietary supplements within 6 weeks
- Supplements include but are not limited to ephedra, yohimbine, pro‐hormones, creatine or anabolic

Exclusion Criteria:

Orthopedic limitations
Current smokers
Pregnant or breastfeeding women
Obesity (BMI ≥30 kg/m2)
Sedentary lifestyle (vigorous exercise <90 min/week), 6) a recent history of a bacterial infection
Use of anti‐inflammatory medication within the preceding 6 weeks.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/01/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Bruce Johnson, Ph.D.	Open for enrollment	Contact information: Jessica Johnston 5072662696 johnston.jessica1@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Bruce Johnson, Ph.D.

Open for enrollment

Contact information:

Jessica Johnston

5072662696

johnston.jessica1@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials